Hyperpolarization demonstrates biocompatibility and enables noninvasive metabolic imaging in cell models, pointing to its potential for research in metabolic dysregulation.
Ketoleucine (α‐ketoisocaproate) is a novel hyperpolarized substrate for noninvasive metabolic imaging, enabling rapid, high‐sensitivity detection of branched‐chain amino acid flux, a pathway that is aberrant in many diseases including cancer and Alzheimer's disease. Utilizing NMR Signal Amplification by Reversible Exchange (SABRE) with an 80:20 acetone:water solvent system, we achieved >11% polarization of [1‐ 13 C]ketoleucine (corresponding to signal enhancement over 230,000‐fold at 0.55 T) at 70 mM within 2 min, using parahydrogen as a cheap and fast source of hyperpolarization. A two‐stage liquid–liquid extraction and gas stripping protocol removes excess excipients, yielding a biocompatible aqueous solution of [1‐ 13 C]ketoleucine (79 ± 10 mM). When mixed with Saccharomyces cerevisiae (Baker's yeast), hyperpolarized [1‐ 13 C]ketoleucine produced strong, long‐lasting signals, where downstream metabolites are observed for >200 s, allowing first‐order kinetic modeling of CO 2 and bicarbonate. These cell experiments demonstrate both the biocompatibility and signal strength of SABRE–hyperpolarized KL, establishing KL as a versatile hyperpolarized agent and opening avenues for real‐time investigation of metabolic dysregulation in cancer, neurodegenerative disorders, and beyond.
No takes yet. Share an insight, caveat, or question.
TomHon et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: